18F-氟脱氧葡萄糖-正电子发射断层扫描作为大血管血管炎前瞻性纵向队列患者的影像生物标志物
本研究在前瞻性纵向队列中评估18F-氟脱氧葡萄糖(FDG)正电子发射断层扫描(PET)对大血管血管炎(LVV)的临床价值。共115名参与者(56例LVV患者和59名对照者)接受170次FDG-PET扫描。FDG-PET区分临床活动性LVV与对照者的敏感度为85%(95%CI 69,94),特异度为83%(95%CI 71,91)。临床缓解期FDG-PET扫描活跃与未来临床复发相关。
要点
- FDG-PET区分临床活动性LVV与对照者敏感度85%(95%CI 69,94),特异度83%(95%CI 71,91)。
- 临床缓解期LVV患者中41/71(58%)FDG-PET扫描判读为活动性血管炎。
- 临床缓解期PETVAS高者未来复发55%,低者11%(P=0.03),中位随访15个月。
核心结论
- FDG-PET提供关于血管炎症的信息,与LVV的临床评估互补且不同。
- 临床缓解期FDG-PET扫描活跃与未来临床复发相关。
研究设计与样本
- 前瞻性纵向队列研究,纳入大动脉炎和巨细胞动脉炎患者,以及由高脂血症患者、模拟LVV疾病患者和健康对照者组成的对照组。
- 共115名参与者(56例LVV患者和59名对照者)接受170次FDG-PET扫描,LVV患者每6个月接受系列影像检查。
- 计算FDG-PET判读区分临床活动性LVV与对照者及临床缓解患者的敏感度和特异度。
- 采用基于全局动脉FDG摄取定性的PET血管活动评分(PETVAS)研究PET扫描活动与临床特征的关联并预测复发。
主要发现
- FDG-PET区分临床活动性LVV与对照者的敏感度为85%(95%CI 69,94),特异度为83%(95%CI 71,91)。
- 临床缓解期LVV患者中41/71(58%)FDG-PET扫描判读为活动性血管炎。
- 临床疾病活动状态、疾病持续时间、体重指数和糖皮质激素使用与PET扫描活动独立相关。
- 临床缓解期接受PET检查的患者中,PETVAS高者未来临床复发55%,PETVAS低者11%(P=0.03),中位随访15个月。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the clinical value of 18 F-fluorodeoxyglucose (FDG) positron emission tomography (PET) in a prospective cohort of patients with large vessel vasculitis (LVV) and comparator subjects. METHODS: Patients with Takayasu arteritis and giant cell arteritis were studied, along with a comparator group consisting of patients with hyperlipidemia, patients with diseases that mimic LVV, and healthy controls. Participants underwent clinical evaluation and FDG-PET imaging, and patients with LVV underwent serial imaging at 6-month intervals. We calculated sensitivity and specificity of FDG-PET interpretation for distinguishing patients with clinically active LVV from comparator subjects and from patients with disease in clinical remission. A qualitative summary score based on global arterial FDG uptake, the PET Vascular Activity Score (PETVAS), was used to study associations between activity on PET scan and clinical characteristics and to predict relapse. RESULTS: A total of 170 FDG-PET scans were performed in 115 participants (56 patients with LVV and 59 comparator subjects). FDG-PET distinguished patients with clinically active LVV from comparator subjects with a sensitivity of 85% (95% confidence interval [95% CI] 69, 94) and a specificity of 83% (95% CI 71, 91). FDG-PET scans were interpreted as active vasculitis in most patients with LVV in clinical remission (41 of 71 [58%]). Clinical disease activity status, disease duration, body mass index, and glucocorticoid use were independently associated with activity on PET scan. Among patients who underwent PET during clinical remission, future clinical relapse was more common in patients with a high PETVAS than in those with a low PETVAS (55% versus 11%; P = 0.03) over a median follow-up period of 15 months. CONCLUSION: FDG-PET provides information about vascular inflammation that is complementary to, and distinct from, clinical assessment in LVV. FDG-PET scan activity during clinical remission was associated with future clinical relapse.
引用
- Grayson PC, Alehashemi S, Bagheri AA, et al. 18 F-Fluorodeoxyglucose-Positron Emission Tomography As an Imaging Biomarker in a Prospective, Longitudinal Cohort of Patients With Large Vessel Vasculitis. Arthritis Rheumatol. 2018. PMID: 29145713. doi:10.1002/art.40379
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。